Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF) has made significant progress in its collaboration with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care.

Research into developing new antimicrobial resistance treatments in Nigeria and other low/middle-income countries has secured ...

The Harvard Pilgrim Health Care Institute is proud to announce the launch of the Center for Sepsis Epidemiology and ...

Discover how AI tools like AlphaFold and RF Diffusion are revolutionizing protein folding design, medicine, and ...

The Ghana Association of Medical Laboratory Scientists (GAMLS) has called for urgent public health interventions to curb the ...

If you're like me, winter can feel like a season to endure rather than enjoy. The dark days, cold weather, lingering sniffles ...

History has shown us again and again that, so long as inequality goes unchecked, no amount of technology can ensure people are well fed.

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Epicore Biosystems, another company from John Rogers' lab, has raised $26 million in Series B funding, led by the Steele ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

Researchers discovered that gut microbiota-derived hexa-acylated LPS enhances the effectiveness of anti-PD-1 cancer ...